The FDA is amending its label for alemtuzumab, a drug used to treat multiple sclerosis (MS) and leukemia, after 13 patients reported cases of ischemic stroke, hemorrhagic stroke or arterial dissection related to use of the medication.
Showing patients and their primary care doctors pictorial representations of carotid plaque may prompt greater adherence to lifestyle and medication interventions, resulting in lower cardiovascular disease risk within one year, according to a study published Dec. 3 in The Lancet.
Home telemonitoring approaches for heart failure patients are associated with lower odds of death at six months but not beyond that, according to a meta-analysis published in the December issue of Health Affairs.
It takes emergency medical services (EMS) almost four minutes longer to transport cardiac arrest patients from poor neighborhoods to the hospital versus those from high-income neighborhoods, according to a study of 2014 United States EMS data published in JAMA Network Open.
Seniors taking five or more prescription drugs to treat heart failure could be at an increased risk for functional impairment, according to a study published in the Journal of the American Geriatrics Society.
People who experience out-of-hospital cardiac arrest (OHCA) are nearly twice as likely to survive if they are transferred directly to a hospital with 24-hour capability to perform PCI or targeted temperature management (TTM) versus another center, according to a meta-analysis published Nov. 28 in the Journal of the American Heart Association.
Hospitals ranked highest for cardiology and heart surgery by the U.S. News and World Report (USNWR) boast lower 30-day mortality rates for acute MI, heart failure and coronary artery bypass grafting (CABG), according to research published in JAMA Cardiology—but those same hospitals also see similar or higher readmission rates compared with hospitals that aren't ranked at all.
The Tampa Bay Times published a lengthy investigative piece Nov. 28 about recent problems at Johns Hopkins All Children’s Hospital in St. Petersburg, Florida, where the heart surgery unit saw a tripling in its mortality rate from 2015 to 2017.
Contrary to U.S. guidelines, early action against high BP in patients exhibiting signs of hypertension doesn’t reduce their risk of heart disease later in life, according to a study published in the European Heart Journal Nov. 21.
Infrastructure requirements and changing policy are the top barriers to speeding the adoption of value-based care, according to a survey of healthcare executives, clinical leaders and clinicians conducted by NEJM Catalyst.
A new expert consensus document from the American College of Cardiology singled out liraglutide and empagliflozin as the preferred drugs in their classes to reduce cardiovascular risk among patients with type 2 diabetes and atherosclerotic cardiovascular disease.
Sales representatives from medical device companies can provide training and expertise on the latest implantable gadgets but may also be encouraged to upsell physicians on the newest, most expensive products, according to a Nov. 23 article in NPR.